Patents by Inventor Karin Schlotter

Karin Schlotter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phenyl Diazepane Carboxamides and Annelated Phenyl Piperazine Carboxamides Containing Oxygen and Used as Dopamine D3 Antagonists
    Publication number: 20080194539
    Abstract: The invention relates to annelated phenyl piperazine and phenyl diazepane carboxamides of general formula (I) containing oxygen. The compounds are suitable for medical use.
    Type: Application
    Filed: December 27, 2005
    Publication date: August 14, 2008
    Applicant: Schwarz Pharma AG
    Inventors: Peter Gmeiner, Harald Hubner, Karin Schlotter
  • Indolizine Carboxamides and Aza and Diaza Derivatives Thereof
    Publication number: 20080051409
    Abstract: The present invention concerns neuroreceptor-active carboxamide-substituted indolizine derivatives of general formula I wherein X represents a group of general formula X1
    Type: Application
    Filed: July 29, 2005
    Publication date: February 28, 2008
    Inventors: Peter Gmeiner, Harald Hubner, Laura Bettinetti, Karin Schlotter
  • Azaindole Carboxamides
    Publication number: 20070299091
    Abstract: The invention relates to azaindole derivatives of general formula (I), wherein X represents a group of general formula (X1). Said compounds have a therapeutic potential in the treatment of diseases that are accompanied by an impaired dopamine metabolism and/or abnormal serotonin-5-HT1a signal transmission.
    Type: Application
    Filed: November 11, 2005
    Publication date: December 27, 2007
    Inventors: Peter Gmeiner, Karin Schlotter, Harald Huber, Dirk Schmidt, Monika Buchholz
  • Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases
    Publication number: 20050197343
    Abstract: The invention relates to neuroreceptor active N-[(4-phenyl-1-piperazinyl)alkyl]-substituted heteroarene carboxamide of general formula (I) and to structure analogous 2-ferrocenyl compounds of general formula (II) and the utilization thereof for the treatment of CNS diseases, for example, schizophrenia, different forms of depression, neurodegenerative disorders, sexual dysfunctions, cocaine, alcohol, opiate and nicotine addiction, in addition to glaucoma, cognitive disorders, restless leg syndrome, hyperactivity syndrome (ADHS), hyperprolactinemia, hyperprolactinoma, locomotion disorders associated with Parkinson's disease, treatment of L-DOPA and neuroleptic-induced locomotion disorders, for example, akathisia, rigor, dystonia and dyskinesia, wherein the substituents are defined in the description.
    Type: Application
    Filed: July 2, 2003
    Publication date: September 8, 2005
    Inventors: Peter Gmeiner, Harald Hubner, Karin Schlotter